Anton Pavlov recently turned 18 years old. He has entered adulthood, and he already has a favorite thing — he writes his own music and raps. But his life is overshadowed by a rare genetic disease — myodystrophy. This is a progressive weakening of the muscles, leading to a fatal outcome. Anton is in vital need of an expensive and rare medicine, but due to bureaucratic obstacles, he has lost access to it.

Medical scientists Alexander Gireev and Vladimir Shulgin have invented a medicine that can cure any disease, even a cancerous tumor. But the drug that can save the world is becoming a bone of contention for the whole family. Gireev's eldest son, Evgeny, decides to help his father with his promotion. Daughter Polina is sure that her brother needs only fame and money, and he is ready to betray his father. And Gireev himself is not ready for the compromises that the big pharma market demands of him. After all, the production of medicines is a profitable business. And why produce something that will cure people if you can earn more while they are sick?

制药行业对卫生政策有着巨大的影响力。一些公司利用公共资金研发出利润极高的药物，而另一些公司则被发现曾隐瞒严重的药物副作用。抗击新冠疫情的行动进一步助长了制药公司的贪欲。该行业的影响力是否会对公共卫生系统构成威胁呢？该行业……